Cell Signaling Market by Type, Pathway, Product, Technology & Application - Global Forecast to 2022

  • ID: 4244509
  • Report
  • Region: Global
  • 215 Pages
  • Markets and Markets
1 of 6
The Cell Signaling Market is Projected to Reach USD 3.51 Billion by 2022 from USD 2.53 Billion in 2017, at a CAGR of 6.8%

FEATURED COMPANIES

  • Abcam PLC  (U.K.)
  • Abeomics Inc. (U.S.)
  • Biovision Inc. (U.S.)
  • Cell Biolabs Inc. (U.S.)
  • Cisbio Bioassays (France)
  • Merck KGaA (Germany)
  • MORE

Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022

The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising funding for cell-based research activities; introduction of innovative and advanced instruments; and growing biotech and biopharmaceutical industries are driving the global cell signaling market.

The cell signaling market is categorized based on type, product, technology, pathway, application, and region. The type segment includes endocrine, paracrine, autocrine, juxtacrine, and other types (neuronal and intracrine signaling). The endocrine segment is estimated to account the largest share of the cell signaling market in 2017.

By product, the cell signaling market is categorized into consumables (antibodies, reagents, assay kits and other consumables) and instruments. In 2017, the consumables segment is estimated to account the largest share of the market.

The technology segment of the cell signaling market includes microscopy, western blotting, immunohistochemistry (IHC), flow cytometry, enzyme-linked immunosorbent assay (ELISA), mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The microscopy segment is estimated to account for the largest share of the cell signaling market in 2017.

On the basis of the pathway, the cell signaling market is categorized into Akt, AMP-activated protein kinase (AMPK), ErbB/HER, Hedgehog (Hh), Janus kinase and signal transducer and activator of transcription (JAK/STAT), NF-?B, Notch, and other signaling pathways. In 2017, the Akt segment is estimated to account the largest share of the cell signaling market.

The application segment of cell signaling market includes research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The research applications segment is estimated to account for the largest share of the cell signaling market in 2017.

Geographically, the cell signaling market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).

The major players in the cell signaling market include Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Bio-Techne Corporation (U.S.), and Abcam plc (U.K.)

Research Coverage

Apart from comprehensive geographic analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles also comprise of product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. This market research data can help key players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the cell signaling market.

Reasons to Buy the Report

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthening their shares in the cell signaling market.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the cell signaling market. The report analyzes the cell signaling market, by type, product, technology, pathway, application, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the cell signaling market
  • Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the cell signaling market
  • Market Development: Comprehensive information about emerging markets. This report analyses the cell signaling market across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell signaling market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abcam PLC  (U.K.)
  • Abeomics Inc. (U.S.)
  • Biovision Inc. (U.S.)
  • Cell Biolabs Inc. (U.S.)
  • Cisbio Bioassays (France)
  • Merck KGaA (Germany)
  • MORE
1 Introduction

    1.1 Objectives of the Study

    1.2 Market Definition

    1.3 Market Scope

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency

    1.5 Limitations

    1.6 Stakeholders

2 Research Methodology

    2.1 Secondary Data

           2.1.1 Key Data From Secondary Sources

    2.2 Primary Data

           2.2.1 Key Data From Primary Sources

    2.3 Market Size Estimation

           2.3.1 Bottom-Up Approach

           2.3.2 Top-Down Approach

    2.4 Market Breakdown & Data Triangulation

    2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights

    4.1 Cell Signaling: Market Overview

    4.2 Geographic Analysis: Market By Signaling Type & Region (2017)

    4.3 Cell Signaling Market, By Pathway, 2017-2022

    4.4 Geographical Snapshot of the Market

5 Market Overview

    5.1 Introduction

    5.2 Market Dynamics

           5.2.1 Drivers

                    5.2.1.1 Rising Incidence of Chronic Diseases

                    5.2.1.2 Availability of Funding for Cell-Based Research

                    5.2.1.3 Technological Advancements in Cell-Based Research Instruments

                    5.2.1.4 Growth of End-Use Industries

           5.2.2 Restraints

                    5.2.2.1 High Cost of Cell Signaling Systems

                    5.2.2.2 Ethical Issues Related to Embryonic Stem Cell Signaling Research

           5.2.3 Opportunities

                    5.2.3.1 Emerging Markets

                    5.2.3.2 Emergence of Microfluidics in Cell Biology Research

           5.2.4 Challenges

                    5.2.4.1 Complexities Related to Antibody and Reagent Development

6 Global Cell Signaling Market, By Signaling Type

    6.1 Introduction

    6.2 Endocrine Signaling

    6.3 Paracrine Signaling

    6.4 Autocrine Signaling

    6.5 Juxtacrine Signaling

    6.6 Other Signaling Types

7 Global Cell Signaling Market, By Product

    7.1 Introduction

    7.2 Consumables

           7.2.1 Antibodies

           7.2.2 Reagents

           7.2.3 Assay Kits

           7.2.4 Other Consumables

    7.3 Instruments

8 Global Cell Signaling Market, By Technology

    8.1 Introduction

    8.2 Microscopy

    8.3 Flow Cytometry

    8.4 Mass Spectrometry

    8.5 Western Blotting

    8.6 Elisa

    8.7 Immunohistochemistry

    8.8 Other Technologies

9 Global Cell Signaling Market, By Pathway

    9.1 Introduction

    9.2 AKT Signaling Pathway

    9.3 AMPK Signaling Pathway

    9.4 ErbB/HER Signaling Pathway

    9.5 Hedgehog Signaling Pathway

    9.6 JAK/STAT Signaling Pathway

    9.7 Notch Signaling Pathway

    9.8 NF-KB Signaling Pathway

    9.9 Other Signaling Pathways

10 Cell Signaling Market, By Application

     10.1 Introduction

     10.2 Research Applications

             10.2.1 Cancer Research

             10.2.2 Immunology Research

             10.2.3 Stem Cells Research

             10.2.4 Other Research Applications

     10.3 Medical Applications

11 Global Cell Signaling Market, By Region

     11.1 Introduction

     11.2 North America

             11.2.1 U.S.

             11.2.2 Canada

     11.3 Europe

             11.3.1 Germany

             11.3.2 France

             11.3.3 U.K.

             11.3.4 Italy

             11.3.5 Spain

             11.3.6 Rest of Europe (RoE)

     11.4 Asia

             11.4.1 China

             11.4.2 Japan

             11.4.3 India

             11.4.4 Rest of Asia (RoA)

     11.5 Rest of the World (RoW)

12 Competitive Landscape

     12.1 Introduction

     12.2 Vendor Dive Overview

             12.2.1 Vanguards

             12.2.2 Innovators

             12.2.3 Dynamic Players

             12.2.4 Emerging Players

     12.3 Competitive Benchmarking

             12.3.1 Product Offerings (For All 25 Players)

             12.3.2 Business Strategy (For All 25 Players)

13 Company Profiles

     13.1 Merck KGaA

     13.2 Thermo Fisher Scientific Inc.

     13.3 Becton, Dickinson and Company

     13.4 Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)

     13.5 Bio-Rad Laboratories, Inc.

     13.6 Perkinelmer, Inc

     13.7 Qiagen N.V.

     13.8 Cell Signaling Technology, Inc.

     13.9 Promega Corporation

     13.10 Bio-Techne Corporation

14 Key Innovators

     14.1 Cisbio Bioassays

             14.1.1 Innovations

     14.2 Miltenyi Biotec

             14.2.1 Innovations

     14.3 Cell Biolabs, Inc.

             14.3.1 Innovations

List of Tables
Table 1 Cell Signaling: Market Snapshot
Table 2 Projected Increase in Cancer Patients, By Type (2012, 2015, and 2035)
Table 3 Cell Signaling Market Size, By Type, 2015-2022 (USD Million)
Table 4 Endocrine Signaling Market Size, By Region, 2015-2022 (USD Million)
Table 5 Paracrine Signaling Market Size, By Region, 2015-2022 (USD Million)
Table 6 Autocrine Signaling Market Size, By Region, 2015-2022 (USD Million)
Table 7 Juxtacrine Signaling Market Size, By Region, 2015-2022 (USD Million)
Table 8 Other Cell Signaling Types Market Size, By Region, 2015-2022 (USD Million)
Table 9 Cell Signaling Market Size, By Product, 2015-2022 (USD Million)
Table 10 Cell Signaling Consumables Market Size, By Region, 2015-2022 (USD Million)
Table 11 Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 12 Cell Signaling Antibodies Market Size, By Region, 2015-2022 (USD Million)
Table 13 Cell Signaling Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 14 Cell Signaling Assay Kits Market Size, By Region, 2015-2022 (USD Million)
Table 15 Other Cell Signaling Consumables Market Size, By Region, 2015-2022 (USD Million)
Table 16 Cell Signaling Instruments Market Size, By Region, 2015-2022 (USD Million)
Table 17 Cell Signaling Market Size, By Technology, 2015-2022 (USD Million)
Table 18 Cell Signaling Market Size for Microscopy, By Region, 2015-2022 (USD Million)
Table 19 Cell Signaling Market Size for Flow Cytometry, By Region, 2015-2022 (USD Million)
Table 20 Cell Signaling Market Size for Mass Spectrometry, By Region, 2015-2022 (USD Million)
Table 21 Cell Signaling Market Size for Western Blotting, By Region, 2015-2022 (USD Million)
Table 22 Cell Signaling Market Size for Elisa, By Region, 2015-2022 (USD Million)
Table 23 Cell Signaling Market Size for Immunohistochemistry, By Region, 2015-2022 (USD Million)
Table 24 Cell Signaling Market Size for Other Technologies, By Region, 2015-2022 (USD Million)
Table 25 Cell Signaling Market Size, By Pathway, 2015-2022 (USD Million)
Table 26 AKT Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 27 AMPK Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 28 ErbB/HER Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 29 Hedgehog Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 30 JAK/STAT Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 31 Notch Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 32 NF-KB Signaling Pathway Market Size, By Region, 2015-2022 (USD Million)
Table 33 Other Signaling Pathways Market Size, By Region, 2015-2022 (USD Million)
Table 34 Cell Signaling Market Size, By Application, 2015-2022 (USD Million)
Table 35 Cell Signaling Market Size for Research Applications, By Region, 2015-2022 (USD Million)
Table 36 Cell Signaling Market Size for Research Applications, By Type, 2015-2022 (USD Million)
Table 37 Cell Signaling Market Size for Cancer Research, By Region, 2015-2022 (USD Million)
Table 38 Cell Signaling Market Size for Immunology Research, By Region, 2015-2022 (USD Million)
Table 39 Cell Signaling Market Size for Stem Cells Research, By Region, 2015-2022 (USD Million)
Table 40 Cell Signaling Market Size for Other Research Applications, By Region, 2015-2022 (USD Million)
Table 41 Cell Signaling Market Size for Medical Applications, By Region, 2015-2022 (USD Million)
Table 42 Cell Signaling Market Size By Region, 2015-2022 (USD Million)
Table 43 North America: Market Size By Country, 2015-2022 (USD Million)
Table 44 North America: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 45 North America: Market Size By Pathway, 2015-2022 (USD Million)
Table 46 North America: Market Size By Product, 2015-2022 (USD Million)
Table 47 North America: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 48 North America: Market Size By Technology, 2015-2022 (USD Million)
Table 49 North America: Market Size By Application, 2015-2022 (USD Million)
Table 50 North America: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 51 U.S.: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 52 U.S.: Market Size By Pathway, 2015-2022 (USD Million)
Table 53 U.S.: Market Size By Product, 2015-2022 (USD Million)
Table 54 U.S.: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 55 U.S.: Market Size By Technology, 2015-2022 (USD Million)
Table 56 U.S.: Market Size By Application, 2015-2022 (USD Million)
Table 57 U.S.: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 58 Canada: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 59 Canada: Market Size By Pathway, 2015-2022 (USD Million)
Table 60 Canada: Market Size By Product, 2015-2022 (USD Million)
Table 61 Canada: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 62 Canada: Market Size By Technology, 2015-2022 (USD Million)
Table 63 Canada: Market Size By Application, 2015-2022 (USD Million)
Table 64 Canada: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 65 Europe: Market Size By Country, 2015-2022 (USD Million)
Table 66 Europe: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 67 Europe: Market Size By Pathway, 2015-2022 (USD Million)
Table 68 Europe: Market Size By Product, 2015-2022 (USD Million)
Table 69 Europe: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 70 Europe: Market Size By Technology, 2015-2022 (USD Million)
Table 71 North America: Market Size By Application, 2015-2022 (USD Million)
Table 72 Europe: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 73 Germany: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 74 Germany: Market Size By Pathway, 2015-2022 (USD Million)
Table 75 Germany: Market Size By Product, 2015-2022 (USD Million)
Table 76 Germany: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 77 Germany: Market Size By Technology, 2015-2022 (USD Million)
Table 78 Germany: Market Size By Application, 2015-2022 (USD Million)
Table 79 Germany: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 80 France: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 81 France: Market Size By Pathway, 2015-2022 (USD Million)
Table 82 France: Market Size By Product, 2015-2022 (USD Million)
Table 83 France: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 84 France: Market Size By Technology, 2015-2022 (USD Million)
Table 85 France: Market Size By Application, 2015-2022 (USD Million)
Table 86 France: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 87 U.K.: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 88 U.K.: Market Size By Pathway, 2015-2022 (USD Million)
Table 89 U.K.: Market Size By Product, 2015-2022 (USD Million)
Table 90 U.K.: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 91 U.K.: Market Size By Technology, 2015-2022 (USD Million)
Table 92 U.K.: Market Size By Application, 2015-2022 (USD Million)
Table 93 U.K.: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 94 Italy: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 95 Italy: Market Size By Pathway, 2015-2022 (USD Million)
Table 96 Italy: Market Size By Product, 2015-2022 (USD Million)
Table 97 Italy: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 98 Italy: Market Size By Technology, 2015-2022 (USD Million)
Table 99 Italy: Market Size By Application, 2015-2022 (USD Million)
Table 100 Italy: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 101 Spain: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 102 Spain: Market Size By Pathway, 2015-2022 (USD Million)
Table 103 Spain: Market Size By Product, 2015-2022 (USD Million)
Table 104 Spain: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 105 Spain: Market Size By Technology, 2015-2022 (USD Million)
Table 106 Spain: Market Size By Application, 2015-2022 (USD Million)
Table 107 Spain: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 108 RoE: Market Size, By Signaling Type, 2015-2022 (USD Million)
Table 109 RoE: Market Size By Pathway, 2015-2022 (USD Million)
Table 110 RoE: Market Size By Product, 2015-2022 (USD Million)
Table 111 RoE: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 112 RoE:Market Size By Technology, 2015-2022 (USD Million)
Table 113 RoE: Market Size By Application, 2015-2022 (USD Million)
Table 114 RoE: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 115 Asia: Market Size By Country, 2015-2022 (USD Million)
Table 116 Asia: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 117 Asia: Market Size By Pathway, 2015-2022 (USD Million)
Table 118 Asia: Market Size By Product, 2015-2022 (USD Million)
Table 119 Asia: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 120 Asia: Market Size By Technology, 2015-2022 (USD Million)
Table 121 Asia: Market Size By Application, 2015-2022 (USD Million)
Table 122 Asia: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 123 China: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 124 China: Market Size By Pathway, 2015-2022 (USD Million)
Table 125 China: Market Size By Product, 2015-2022 (USD Million)
Table 126 China: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 127 China:Market Size By Technology, 2015-2022 (USD Million)
Table 128 China: Market Size By Application, 2015-2022 (USD Million)
Table 129 China: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 130 Japan: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 131 Japan: Market Size By Pathway, 2015-2022 (USD Million)
Table 132 Japan: Market Size By Product, 2015-2022 (USD Million)
Table 133 Japan: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 134 Japan: Market Size By Technology, 2015-2022 (USD Million)
Table 135 Japan: Market Size By Application, 2015-2022 (USD Million)
Table 136 Japan: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 137 India: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 138 India: Market Size By Pathway, 2015-2022 (USD Million)
Table 139 India: Market Size By Product, 2015-2022 (USD Million)
Table 140 India: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 141 India: Market Size By Technology, 2015-2022 (USD Million)
Table 142 India: Market Size By Application, 2015-2022 (USD Million)
Table 143 India: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 144 RoA: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 145 RoA: Market Size By Pathway, 2015-2022 (USD Million)
Table 146 RoA: Market Size By Product, 2015-2022 (USD Million)
Table 147 RoA: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 148 RoA: Market Size By Technology, 2015-2022 (USD Million)
Table 149 RoA: Market Size By Application, 2015-2022 (USD Million)
Table 150 RoA: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)
Table 151 RoW: Market Size By Signaling Type, 2015-2022 (USD Million)
Table 152 RoW: Market Size By Pathway, 2015-2022 (USD Million)
Table 153 RoW: Market Size By Product, 2015-2022 (USD Million)
Table 154 RoW: Cell Signaling Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 155 RoW: Market Size By Technology, 2015-2022 (USD Million)
Table 156 RoW: Market Size By Application, 2015-2022 (USD Million)
Table 157 RoW: Cell Signaling Research Applications Market Size, By Type, 2015-2022 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Cell Signaling Market: Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Cell Signaling Market Size, By Signaling Type, 2017 vs 2022 (USD Billion)
Figure 6 Cell Signaling Market Size, By Pathway, 2017 vs 2022 (USD Billion)
Figure 7 Cell Signaling Market Size, By Product, 2017 vs 2022 (USD Billion)
Figure 8 Cell Signaling Market Size, By Technology, 2017 vs 2022 (USD Billion)
Figure 9 Cell Signaling Market Size, By Application, 2017 vs 2022 (USD Billion)
Figure 10 Cell Signaling Market Size, By Region, 2017 vs 2022 (USD Billion)
Figure 11 Growing Prevalence of Chronic Diseases and Availability of Funding for Cell-Based Research are Driving the Growth of the Cell Signaling Market During the Forecast Period
Figure 12 North America & Endocrine Segments are Estimated to Command the Largest Market Share in 2017
Figure 13 AKT Segment to Register the Highest CAGR During the Forecast Period
Figure 14 Asia to Register the Highest CAGR Between 2017 & 2022
Figure 15 Cell Signaling Market: Drivers, Restraints, and Opportunities
Figure 16 Diabetes Cases, 2015 vs 2040 (Million)
Figure 17 Endocrine Signaling Segment to Dominate the Cell Signaling Market During the Forecast Period
Figure 18 North America to Dominate the Endocrine Signaling Market During the Forecast Period
Figure 19 North America to Dominate the Autocrine Signaling Market During the Forecast Period
Figure 20 Consumables to Dominate the Cell Signaling Market During the Forecast Period
Figure 21 Antibodies to Dominate the Cell Signaling Consumables Market in 2017-2022
Figure 22 North America to Dominate the Cell Signaling Instruments Market During 2017-2022
Figure 23 Microscopy Segment to Dominate the Cell Signaling Technology Market During the Forecast Period
Figure 24 AKT Pathway Segment to Dominate the Cell Signaling Market in 2017-2022
Figure 25 Research Applications Segment Will Continue to Dominate the Cell Signaling Market in 2022
Figure 26 Asian Cell Signaling Market to Register the Highest CAGR During the Forecast Period
Figure 27 North America: Cancer Incidence & Mortality, 2012-2035
Figure 28 North America: Market Snapshot
Figure 29 U.S.: Cancer Incidence & Mortality, 2012-2035
Figure 30 Endocrine Segment to Account for the Largest Share of the U.S. Cell Signaling Market in 2017
Figure 31 Canada: Cancer Incidence & Mortality, 2012-2035
Figure 32 Europe: Cancer Incidence & Mortality, 2012-2035
Figure 33 Europe: Market Snapshot
Figure 34 Germany: Cancer Incidence & Mortality, 2012-2035
Figure 35 Germany: Revenue & R&D Expenditures of Major Biotechnology Companies, 2012-2015 (USD Billion)
Figure 36 AKT Segment to Register the Highest CAGR in the German Cell Signaling Market During the Forecast Period
Figure 37 France: Cancer Incidence & Mortality, 2012-2035
Figure 38 U.K.: Cancer Incidence & Mortality, 2012-2035
Figure 39 Italy: Cancer Incidence & Mortality, 2012-2035
Figure 40 Spain: Cancer Incidence & Mortality, 2012-2035
Figure 41 Asia: Cancer Incidence & Mortality, 2012-2035
Figure 42 Asia: Market Snapshot
Figure 43 China: Cancer Incidence & Mortality, 2012-2035
Figure 44 Japan: Cancer Incidence & Mortality, 2012-2035
Figure 45 Consumables Segment to Register the Highest CAGR in the Japanese Cell Signaling Market During the Forecast Period
Figure 46 India: Cancer Incidence & Mortality, 2012-2035
Figure 47 RoW: Market Snapshot
Figure 48 Dive Chart: Cell Signaling Market
Figure 49 Merck KGaA: Company Snapshot (2016)
Figure 50 Merck KGaA: Product Offering Scorecard
Figure 51 Merck KGaA: Business Strategy Scorecard
Figure 52 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 53 Thermo Fisher Scientific Inc.: Product Offering Scorecard
Figure 54 Thermo Fisher Scientific Inc.: Business Strategy Scorecard
Figure 55 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 56 Becton, Dickinson and Company: Product Offering Scorecard
Figure 57 Becton, Dickinson and Company: Business Strategy Scorecard
Figure 58 Danaher Corporation: Company Snapshot (2016)
Figure 59 Danaher Corporation: Product Offering Scorecard
Figure 60 Danaher Corporation: Business Strategy Scorecard
Figure 61 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 62 Bio-Rad Laboratories, Inc.: Product Offering Scorecard
Figure 63 Bio-Rad Laboratories, Inc.:: Business Strategy Scorecard
Figure 64 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 65 Perkinelmer, Inc.: Product Offering Scorecard
Figure 66 Perkinelmer, Inc.: Business Strategy Scorecard
Figure 67 Qiagen N.V.: Company Snapshot (2016)
Figure 68 Qiagen N.V.: Product Offering Scorecard
Figure 69 Qiagen N.V.: Business Strategy Scorecard
Figure 70 Cell Signaling Technology Inc.: Product Offering Scorecard
Figure 71 Cell Signaling Technology Inc.: Business Strategy Scorecard
Figure 72 Promega Corporation: Product Offering Scorecard
Figure 73 Promega Corporation: Business Strategy Scorecard
Figure 74 Bio-Techne Corporation: Company Snapshot (2016)
Figure 75 Bio-Techne Corporation: Product Offering Scorecard
Figure 76 Bio-Techne Corporation: Business Strategy Scorecard
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abcam PLC  (U.K.)
  • Abeomics Inc. (U.S.)
  • Beckman Coulter Inc. (U.S.) (A Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (U.S.)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Bio-Techne Corporation (U.S.)
  • Biovision Inc. (U.S.)
  • Bps Bioscience Inc. (U.S.)
  • Cell Biolabs Inc. (U.S.)
  • Cell Signaling Technology Inc. (U.S.)
  • Cisbio Bioassays (France)
  • Full Moon Biosystems Inc. (U.S.)
  • Medical & Biological Laboratories Co. Ltd. (Japan)
  • Merck KGaA (Germany)
  • Miltenyi Biotec (Germany)
  • Perkinelmer Inc. (U.S.)
  • Promega Corporation (U.S.)
  • Qiagen N.V. (Netherlands)
  • Raybiotech Inc. (U.S.)
  • Rockland Immunochemicals Inc. (U.S.)
  • Santa Cruz Biotechnology Inc. (U.S.)
  • Sino Biological Inc. (U.S.)
  • Stressmarq Biosciences Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Tonbo Biosciences (U.S.)
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll